Karoon Gas. What a difference a day makes A$1.63 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Similar documents
Karoon Gas. Losing the deal A$1.83 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Platinum Asset Management

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

SG Fleet Group. Another UK acquisition. Earnings and target price revision

Oil Search. Proving up PNG A$7.11 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

Automotive Holdings Group

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sims Metal Management

National Australia Bank

Tox Free Solutions. Winning work again A$2.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Senex Energy Production and revenue unsurprised, cash builds on lower capex

Fisher & Paykel Healthcare

Origin Energy. 4Q Production. ORG reported its 4 th quarter production report, following on ConocoPhilips quarterly result.

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Bendigo and Adelaide Bank

Whitehaven Coal. China outlook drives impairments A$1.04 AUSTRALIA. Event. Impact. Earnings and target price revision.

Oz Minerals. On track to meet guidance A$6.51 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA

Kingsgate Consolidated

Orocobre. Upside exposure fading. Earnings and target price revision. Price catalyst. Catalyst: Update on projects or Q1 report

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Meridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Perseus Mining. Revised Sissingué plan A$0.31 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision.

Spotless Group Holdings

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Coca-Cola Amatil. Not as fizzy as it looks A$8.78 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Oz Minerals. Solid start to the year A$5.62 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Nuplex Industries. Should benefit from a weak Kiwi NZ$4.55 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Fortescue Metals Group

Pilbara Minerals (PLS AU) Ramp-up gaining traction

NEW ZEALAND Price Valuation NZ$ 1.74 Event 12-month target NZ$ month TSR % -10.1

Super Retail Group (SUL AU) Are we there yet?

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Fisher & Paykel Healthcare

CIMIC Group. Earnings and target price revision. No change. Price catalyst. Catalyst: Q1 earnings 13 April. Action and recommendation

ANZ Bank. The Dis-Associates. Earnings and target price revision. No change. Price catalyst. Catalyst: 3Q15 Trading Update. Action and recommendation

AUSTRALIA Price Valuation A$ 7.52 Event 12-month target A$ month TSR % +3.4

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Horizon Oil Gas commercialisation progressing Event

Kiwi Property Group. Land banking for the future NZ$1.43 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Generation Healthcare REIT

PanAust. Larger impairment and dividend cut A$1.35 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Genworth Mortgage Insurance Australia

Vista Group International

Healthcare. Currency adjustments AUSTRALIA. Event. Impact. Outlook COH 8.0% RMD 6.9% CSL 6.0% ANN 5.0% SHL 2.6%

Downer EDI Two out of three ain t bad Event

SingTel. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Outperform.

Independence Group NL

Premier Investments. Making a move? A$14.18 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Ramsay Health Care (RHC AU) RHC UK on the mend?

Saracen Mineral Holdings

Iron Mountain. US$10 worth Recalling at investor day US$31.83 UNITED STATES. Event. Impact. Earnings and target price revision.

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

ANZ Bank. What execution risk? Earnings and target price revision. Price catalyst. Catalyst: 1Q17 Trading update, February 2017.

Silver Lake Resources

Oz Minerals. Raises copper production outlook A$9.08 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Auckland International Airport

Carsales.com. Motoring along nicely A$10.23 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Origin Energy & Santos S&P moving the goal posts

SingTel. Optus rises A$3.98 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Genesis Energy. A 9% FCF yield and you call underperform? NZ$1.71 NEW ZEALAND. Event. Impact. Earnings and target price revision.

Aust. General Insurance

Dexus Property Group. Infra driving industrial demand A$9.94 AUSTRALIA. Event. Impact. Earnings and target price revision.

Australian Banks. Money Talks vertically challenged AUSTRALIA. Inside. Majors average short positions and banks index

3P Learning. Coming to America... A$2.55 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

BHP Billiton. Mad Dog 2 gets FID AUSTRALIA/ UNITED KINGDOM/ SOUTH AFRICA. Event. Impact. Earnings and target price revision.

Australian Mobile Market

Evolution Mining. Cowal pushes EVN beyond 800kozpa A$1.10 AUSTRALIA. Event. Impact. Earnings and target price revision.

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Ryman Healthcare. Arrested development NZ$9.60 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Aussie Macro Moment. Budget 16/17 careful consolidation AUSTRALIA. Event. Impact. Outlook

Adelaide Brighton. Overcoming headwinds A$5.45 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Newcrest Mining. Strong production result A$21.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Asaleo Care. NZ$ pulped. We review the outlook for Asaleo. Earnings and target price revision. Price catalyst. Catalyst: CY15 results.

Fisher & Paykel Healthcare

Doray Minerals. Mine life upside at Andy Well A$0.44 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

National Australia Bank

Sandfire Resources. Strong result but guidance light A$6.10 AUSTRALIA. Event. Impact. Earnings and target price revision.

Australian Banks. Funding markets open for now

Australian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA

AUSTRALIA Price Event Valuation A$ month target A$ 5.20

Nine Entertainment Co.

Iluka Resources. A soft start to FY15 A$7.73 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

CSL. New competitor on the block A$89.68 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Fortescue Metals Group

Alumina. Multiple tailwinds take hold A$1.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Filling in the gaps. Earnings and target price revision. Price catalyst. Action and recommendation

Aventus Retail Property Fund

Transcription:

AUSTRALIA KAR AU Price (at 05:10, 16 Mar 2017 GMT) Outperform A$1.63 Valuation A$ - DCF (WACC 11.1%, beta 1.7, ERP 5.0%, RFR 3.3%) 2.79 12-month target A$ 2.40 12-month TSR % +47.7 Volatility Index High GICS sector Energy Market cap A$m 398 30-day avg turnover A$m 0.9 Number shares on issue m 245.1 Investment fundamentals Year end 30 Jun 2016A 2017E 2018E 2019E Revenue m 0.0 0.0 0.0 0.0 EBIT m -23.5-25.4-29.4-20.4 Reported profit m -105.1-18.7-27.9-20.2 Adjusted profit m -22.1-24.0-27.9-20.2 Gross cashflow m -16.2-19.4-14.4-16.1 CFPS -6.6-7.9-5.9-6.6 CFPS growth % 1.2-20.6 26.1-11.9 EPS adj -9.0-9.8-11.4-8.2 EPS adj growth % -2.5-8.6-16.5 27.6 Total DPS 0.0 0.0 0.0 0.0 Total div yield % 0.0 0.0 0.0 0.0 ROA % -2.3-2.8-3.2-2.0 ROE % -2.4-2.8-3.3-2.1 EV/EBITDA x 3.0 2.5 3.3 3.2 Net debt/equity % -55.9-47.4-7.1-0.5 P/BV x 0.5 0.5 0.5 0.4 KAR AU vs Small Ordinaries, & rec history Note: Recommendation timeline - if not a continuous line, then there was no Macquarie coverage at the time or there was an embargo period. Source: FactSet, Macquarie Research, March 2017 (all figures in AUD unless noted) What a difference a day makes Event Petrobras (PBR US, US$9.37, Neutral, TP: US$9.30) announced that the Federal Accounting Court (TCU) has allowed the company to conclude the sale process for two of its projects, one of which are the two assets being sold to KAR, Bauna and Tartaruga. Impact The first pin falls... A day after their H1FY17 results, KAR have been given a positive sign from the Brazilian legal system that their proposed acquisition of PBR s two assets will go ahead. In amongst the decision handed down by the TCU was an allowance that the Bauna and Tartaruga deal could proceed. We have previously highlighted the transformational nature of the deal KAR are negotiating with PBR. but more judgements await. Whilst the language in PBR s announcement implies that the deal may now conclude, a crucial decision has yet to come. The Federal Regional Court of the 5th Region (TRF-5) has scheduled a court date for March 23, which could mark the next important date for KAR. However, given the multiple legal challenges and appeals to date, we are uncertain if this date will mark the end of the long hold placed on the process. We maintain that if the deal closes, it is unlikely to do so until mid-2017. Earnings and target price revision No change. Price catalyst 12-month price target: A$2.40 based on a DCF methodology. Catalyst: March 23 TRF-5 court date. Action and recommendation Maintain Outperform. Whilst this announcement is positive, there are still many hurdles yet before the deal closes. We currently do not attribute value in our DCF for the assets, and the overall impact on the company will come down to the final price, working interest and funding arrangement. 17 March 2017 Macquarie Securities (Australia) Limited Please refer to page 4 for important disclosures and analyst certification, or on our website www.macquarie.com/research/disclosures.

Fig 1 financials (KAR) Share Price: A$1.78 Outperform Shares: 244.9m Profit & Loss 2H16a 1H17e FY16a FY17e FY18e FY19e Price assumptions 2H16a 1H17e FY16a FY17e FY18e FY19e Sales Revenue A$m - - - - - - US$/A$ 0.75 0.74 0.73 0.75 0.74 0.74 add other income A$m 0-0 - - - Domestic gas A$/GJ NA NA 7.75 7.30 7.32 7.47 Total revenue A$m 0-0 - - - Oil-WTI US$/bbl 39.39 46.99 41.88 50.24 55.00 53.63 less operating costs A$m (10) (12) (18) (21) (16) (16) EBITDAX A$m (10) (12) (18) (21) (16) (16) Production 2H16a 1H17e FY16a FY17e FY18e FY19e less exploration expensed A$m (1) (1) (2) (1) (9) - Natural gas PJ - - - - - - EBITDA A$m (10) (12) (19) (21) (25) (16) Crude mmbbl - - - - - - less dep. & amort. A$m (1) (0) (1) (1) (1) (1) Condensate mmbbl - - - - - - less other non-cash costs A$m - - - - - - LPG k tonnes - - - - - - EBIT A$m (13) (14) (24) (25) (29) (20) LNG m tonnes - - - - - - less net interest A$m 0 0 1 1 2 0 Total production mmboe - - - - - - Pre-tax operating profit A$m (12) (14) (22) (24) (28) (20) less tax expense (incl PRRT) A$m - - - - - - Net operating profit A$m (12) (14) (22) (24) (28) (20) 2.00 mmboe Gas Crude Condensate LPG LNG add non-recurring items A$m (9) 5 (83) 5 - - 1.80 Reported profit A$m (21) (8) (105) (19) (28) (20) 1.60 Adjusted profit A$m (12) (14) (22) (24) (28) (20) 1.40 EPS (Adjusted) Acps (5) (6) (9) (10) (11) (8) EPS Grow th % (23%) (12%) (2%) (9%) (17%) 28% DPS (Ordinary & Special) Acps - - - - - - Franking % 100% 100% 100% 100% 100% 100% EFPOWA shares on issue m 245 245 245 245 245 245 0.00 3Q15 3Q16 3Q17 3Q18 3Q19 3Q20 Cashflow Analysis 2H16a 1H17e FY16a FY17e FY18e FY19e Reserves FY16a FY17e FY18e FY19e Cash from operations A$m 2 1 3 3 2 0 Natural gas Tcf - - - - less operating costs A$m (10) (11) (20) (20) (16) (16) Condensate mmbbl - - - - less interest paid A$m (0) (0) (0) (0) - - Oil mmbbl - - - - less tax paid A$m (13) 0 (13) 0 - - Total 2P reserves mmboe - - - - Gross cashflow from operation A$m (22) (10) (30) (18) (14) (16) Contingent resources mmbbl - - - - less exploration & evaluation A$m (15) (30) (55) (50) (329) (294) Total reserves & resources mmboe - - - - less acq./inv. A$m (0) 0 0 (20) - - add other A$m - - - - - - 2P Reserves / production years nmf nmf nmf nmf less dividends A$m - - - - - - EV / 1P reserves A$/boe nmf nmf nmf nmf add debt movements A$m - - - - - - EV / 2P reserves A$/boe nmf nmf nmf nmf add equity movements A$m (1) (1) (3) (1) - 257 EV / Total resources A$/boe nmf nmf nmf nmf Net cashflow A$m (37) (40) (88) (89) (343) (54) EV / 1P reserves US$/boe nmf nmf nmf nmf add exchange rate adj. A$m (6) 11 14 11 - - EV / 2P reserves US$/boe nmf nmf nmf nmf Increase in cash A$m (44) (29) (74) (78) (343) (54) EV / Total resources US$/boe nmf nmf nmf nmf Net debt at year end A$m (480) (450) (480) (402) (59) (5) 1.20 1.00 0.80 0.60 0.40 0.20 Balance sheet 2H16a 1H17e FY16a FY17e FY18e FY19e Per bbl statistics 2H16a 1H17e FY16a FY17e FY18e FY19e Cash & cash eq. A$m 480 450 480 402 59 5 Sales Revenue / boe US$/boe nmf nmf nmf nmf nmf nmf Current assets A$m 490 463 490 414 71 17 EBIT / boe US$/boe nmf nmf nmf nmf nmf nmf Fixed assets A$m 428 476 428 516 834 1,127 Profit / boe US$/boe nmf nmf nmf nmf nmf nmf Total assets A$m 917 939 917 930 905 1,144 Opex/boe US$/boe nmf nmf nmf nmf nmf nmf Current liabilities A$m 14 37 14 37 37 37 Capex/boe US$/boe nmf nmf nmf nmf nmf nmf Total liabilities A$m 59 82 59 82 82 82 DDA/boe US$/boe nmf nmf nmf nmf nmf nmf Shareholder equity A$m 858 857 858 848 823 1,062 Cash flow /boe US$/boe nmf nmf nmf nmf nmf nmf Ratio analysis 2H16a 1H17e FY16a FY17e FY18e FY19e NPV @ WACC of 11.0% ND/ND+E % nmf nmf (126.8%) (90.1%) (7.7%) (0.5%) Discovered assets A$m A$ps % Interest cover x (108.9 x) (106.4 x) (112.4 x) (193.3 x) nmf nmf Santos Basin, Brazil - Discovered 590 1.18 Dividend payout ratio % - - - - - - Static assets & exploration ROA % (1.4%) (1.5%) (2.6%) (2.7%) (3.3%) (1.8%) Brow se Basin, Aus - Exploration 15 0.06 ROE % (1.4%) (1.6%) (2.4%) (2.8%) (3.3%) (2.1%) Santos Basin, Brazil - Exploration 14 0.05 ROIC % (3.7%) (3.6%) (6.0%) (6.2%) (4.9%) (2.3%) Tumbes Basin, Peru - Exploration 36 0.14 Effective tax rate % - - - - - - Financial assets EBITDA margin % nmf nmf nmf nmf nmf nmf Cash & Investments 402 1.60 EBIT margin % nmf nmf nmf nmf nmf nmf PV of Risked Origin consideration 6 0.03 Free cash flow A$m (37) (40) (85) (68) (343) (310) Cash raised from exercise of options - - Debt - - Valuation 2H16a 1H17e FY16a FY17e FY18e FY19e Corporate costs (69) (0.27) EV/EBITDAX ratio x nmf nmf nmf nmf nmf nmf Core NPV 994 2.79 P/E ratio x nmf nmf nmf nmf nmf nmf Shareprice prem/(disc) to NPV (36%) P/CEPS ratio x nmf nmf nmf nmf nmf nmf - core NPV per share (A$) 2.45 FCF yield % nmf nmf nmf nmf nmf nmf - risked NPV per share (A$) 2.79 Dividend yield % - - - - - - - unrisked NPV per share (A$) 23.21 Sensitivities (Adjusted earnings) NPV FY16a FY17e FY18e FY19e Oil price (+US$1/bbl) A$m 2.79 (22) (24) (28) (48) Source: Macquarie Research, March 2017 17 March 2017 2

Macquarie Quant View The quant model currently holds a reasonably negative view on. The strongest style exposure is Earnings Momentum, indicating this stock has received earnings upgrades and is well liked by sell side analysts. The weakest style exposure is Profitability, indicating this stock is not efficiently converting investments to earnings; proxied by ratios like ROE or ROA. 368/549 Global rank in Energy % of BUY recommendations 100% (4/4) Number of Price Target downgrades 0 Number of Price Target upgrades 0 Fundamentals Attractive Quant Local market rank Global sector rank Displays where the company s ranked based on the fundamental consensus Price Target and Macquarie s Quantitative Alpha model. Two rankings: Local market (Australia & NZ) and Global sector (Energy) Macquarie Alpha Model ranking A list of comparable companies and their Macquarie Alpha model score (higher is better). Factors driving the Alpha Model For the comparable firms this chart shows the key underlying styles and their contribution to the current overall Alpha score. 0.8 0.0-0.9-0.6-2.0-2.1-3.0-2.0-1.0 0.0 1.0 2.0 3.0-100% -80% -60% -40% -20% 0% 20% 40% 60% 80% 100% Valuations Growth Profitability Earnings Momentum Price Momentum Quality Macquarie Earnings Sentiment Indicator The Macquarie Sentiment Indicator is an enhanced earnings revisions signal that favours analysts who have more timely and higher conviction revisions. Current score shown below. Drivers of Stock Return Breakdown of 1 year total return (local currency) into returns from dividends, changes in forward earnings estimates and the resulting change in earnings multiple. 0.2-1.1 0.3-0.9 0.4-0.4-3.0-2.0-1.0 0.0 1.0 2.0 3.0-100% -50% 0% 50% 100% Dividend Return Multiple Return Earnings Outlook 1Yr Total Return What drove this Company in the last 5 years Which factor score has had the greatest correlation with the company s returns over the last 5 years. Price Upside Consensus Recommendation Price to Sales FY0 Interest Cover 3m Earnings Revisions Momentum 6 Month Price to Earnings NTM Price to Earnings FY1-25% -28% -29% - Negatives Positives 29% -30% -20% -10% 0% 10% 20% 30% How it looks on the Alpha model A more granular view of the underlying style scores that drive the alpha (higher is better) and the percentile rank relative to the sector and market. Alpha Model Score Valuation Growth Profitability Earnings Momentum Price Momentum Quality Capital & Funding Liquidity Risk Technicals & Trading Normalized Score -0.95-1.15-0.73-1.53 0.01-0.21-0.31-0.16-1.91-0.35 0.82 Percentile relative to sector(/549) Percentile relative to market(/422) 0 50 100 0 50 100 0 0 1 1 Source (all charts): FactSet, Thomson Reuters, and Macquarie Research. For more details on the Macquarie Alpha model or for more customised analysis and screens, please contact the Macquarie Global Quantitative/Custom Products Group (cpg@macquarie.com) 17 March 2017 3

Important disclosures: Recommendation definitions Macquarie - Australia/New Zealand Outperform return >3% in excess of benchmark return Neutral return within 3% of benchmark return Underperform return >3% below benchmark return Benchmark return is determined by long term nominal GDP growth plus 12 month forward market dividend yield Macquarie Asia/Europe Outperform expected return >+10% Neutral expected return from -10% to +10% Underperform expected return <-10% Macquarie South Africa Outperform expected return >+10% Neutral expected return from -10% to +10% Underperform expected return <-10% Macquarie - Canada Outperform return >5% in excess of benchmark return Neutral return within 5% of benchmark return Underperform return >5% below benchmark return Macquarie - USA Outperform (Buy) return >5% in excess of Russell 3000 index return Neutral (Hold) return within 5% of Russell 3000 index return Underperform (Sell) return >5% below Russell 3000 index return Volatility index definition* This is calculated from the volatility of historical price movements. Very high highest risk Stock should be expected to move up or down 60 100% in a year investors should be aware this stock is highly speculative. High stock should be expected to move up or down at least 40 60% in a year investors should be aware this stock could be speculative. Medium stock should be expected to move up or down at least 30 40% in a year. Low medium stock should be expected to move up or down at least 25 30% in a year. Low stock should be expected to move up or down at least 15 25% in a year. * Applicable to Asia/Australian/NZ/Canada stocks only Recommendations 12 months Note: Quant recommendations may differ from Fundamental Analyst recommendations Financial definitions All "Adjusted" data items have had the following adjustments made: Added back: goodwill amortisation, provision for catastrophe reserves, IFRS derivatives & hedging, IFRS impairments & IFRS interest expense Excluded: non recurring items, asset revals, property revals, appraisal value uplift, preference dividends & minority interests EPS = adjusted net profit / efpowa* ROA = adjusted ebit / average total assets ROA Banks/Insurance = adjusted net profit /average total assets ROE = adjusted net profit / average shareholders funds Gross cashflow = adjusted net profit + depreciation *equivalent fully paid ordinary weighted average number of shares All Reported numbers for Australian/NZ listed stocks are modelled under IFRS (International Financial Reporting Standards). Recommendation proportions For quarter ending 31 December 2016 AU/NZ Asia RSA USA CA EUR Outperform 57.53% 50.72% 45.57% 42.28% 60.58% 52.79% (for global coverage by Macquarie, 8.71% of stocks followed are investment banking clients) Neutral 33.90% 33.97% 43.04% 50.11% 37.23% 35.62% (for global coverage by Macquarie, 8.05% of stocks followed are investment banking clients) Underperform 8.56% 15.30% 11.39% 7.61% 2.19% 11.59% (for global coverage by Macquarie, 4.63% of stocks followed are investment banking clients) KAR AU vs Small Ordinaries, & rec history PBR US vs S&P 500, & rec history (all figures in AUD currency unless noted) (all figures in USD currency unless noted) Note: Recommendation timeline if not a continuous line, then there was no Macquarie coverage at the time or there was an embargo period. Source: FactSet, Macquarie Research, March 2017 12-month target price methodology KAR AU: A$2.40 based on a DCF methodology PBR US: US$9.30 based on a DCF methodology Company-specific disclosures: KAR AU: Macquarie and its affiliates collectively and beneficially own or control 1% or more of any class of Australia Limited's equity securities. MACQUARIE SECURITIES (AUSTRALIA) LIMITED or one of its affiliates is managed an on market buyback for Australia Ltd, in the past 12 months. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/research/disclosures. Date Stock Code (BBG code) Recommendation Target Price 03-Feb-2017 KAR AU Outperform A$2.40 01-Feb-2017 KAR AU Outperform A$2.70 03-Aug-2016 KAR AU Outperform A$2.90 08-Jan-2016 KAR AU Outperform A$3.00 18-Sep-2015 KAR AU Outperform A$3.50 09-Sep-2015 KAR AU Outperform A$2.80 06-Aug-2015 KAR AU Outperform A$3.40 15-Apr-2015 KAR AU Outperform A$3.75 20-Mar-2015 KAR AU Outperform A$4.00 09-Dec-2014 KAR AU Outperform A$4.30 08-Oct-2014 KAR AU Outperform A$5.00 16-May-2014 KAR AU Outperform A$5.25 17-Mar-2014 KAR AU Outperform A$6.00 17 March 2017 4

This publication was disseminated on 16 March 2017 at 14:07 UTC. Macquarie Wealth Management Target price risk disclosures: KAR AU: Any inability to compete successfully in their markets may harm the business. This could be a result of many factors which may include geographic mix and introduction of improved products or service offerings by competitors. The results of operations may be materially affected by global economic conditions generally, including conditions in financial markets. The company is exposed to market risks, such as changes in interest rates, foreign exchange rates and input prices. From time to time, the company will enter into transactions, including transactions in derivative instruments, to manage certain of these exposures. PBR US: Any inability to compete successfully in their markets may harm the business. This could be a result of many factors which may include geographic mix and introduction of improved products or service offerings by competitors. The results of operations may be materially affected by global economic conditions generally, including conditions in financial markets. The company is exposed to market risks, such as changes in interest rates, foreign exchange rates and input prices. From time to time, the company will enter into transactions, including transactions in derivative instruments, to manage certain of these exposures. Analyst certification: We hereby certify that all of the views expressed in this report accurately reflect our personal views about the subject company or companies and its or their securities. We also certify that no part of our compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. The Analysts responsible for preparing this report receive compensation from Macquarie that is based upon various factors including Macquarie Group Limited (MGL) total revenues, a portion of which are generated by Macquarie Group s Investment Banking activities. General disclosure: This research has been issued by Macquarie Securities (Australia) Limited ABN 58 002 832 126, AFSL 238947, a Participant of the ASX and Chi-X Australia Pty Limited. This research is distributed in Australia by Macquarie Wealth Management, a division of Macquarie Equities Limited ABN 41 002 574 923 AFSL 237504 ("MEL"), a Participant of the ASX, and in New Zealand by Macquarie Equities New Zealand Limited ( MENZ ) an NZX Firm. Macquarie Private Wealth s services in New Zealand are provided by MENZ. Macquarie Bank Limited (ABN 46 008 583 542, AFSL No. 237502) ( MBL ) is a company incorporated in Australia and authorised under the Banking Act 1959 (Australia) to conduct banking business in Australia. None of MBL, MGL or MENZ is registered as a bank in New Zealand by the Reserve Bank of New Zealand under the Reserve Bank of New Zealand Act 1989. Apart from Macquarie Bank Limited ABN 46 008 583 542 (MBL), any MGL subsidiary noted in this research,, is not an authorised deposit-taking institution for the purposes of the Banking Act 1959 (Australia) and that subsidiary s obligations do not represent deposits or other liabilities of MBL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of that subsidiary, unless noted otherwise. This research contains general advice and does not take account of your objectives, financial situation or needs. Before acting on this general advice, you should consider the appropriateness of the advice having regard to your situation. We recommend you obtain financial, legal and taxation advice before making any financial investment decision. This research has been prepared for the use of the clients of the Macquarie Group and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient, you must not use or disclose this research in any way. If you received it in error, please tell us immediately by return e-mail and delete the document. We do not guarantee the integrity of any e-mails or attached files and are not responsible for any changes made to them by any other person. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction. This research is based on information obtained from sources believed to be reliable, but the Macquarie Group does not make any representation or warranty that it is accurate, complete or up to date. We accept no obligation to correct or update the information or opinions in it. Opinions expressed are subject to change without notice. The Macquarie Group accepts no liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. The Macquarie Group produces a variety of research products, recommendations contained in one type of research product may differ from recommendations contained in other types of research. The Macquarie Group has established and implemented a conflicts policy at group level, which may be revised and updated from time to time, pursuant to regulatory requirements; which sets out how we must seek to identify and manage all material conflicts of interest. The Macquarie Group, its officers and employees may have conflicting roles in the financial products referred to in this research and, as such, may effect transactions which are not consistent with the recommendations (if any) in this research. The Macquarie Group may receive fees, brokerage or commissions for acting in those capacities and the reader should assume that this is the case. The Macquarie Group s employees or officers may provide oral or written opinions to its clients which are contrary to the opinions expressed in this research. Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/disclosures Macquarie Group 17 March 2017 5